Tag: vaccines

November 29, 2022

Researchers at the Perelman School of Medicine at the University of Pennsylvania have developed an experimental multivalent mRNA-based vaccine against all 20 known subtypes of influenza virus. Their approach differs from previous attempts to craft a universal flu vaccine, by […]

November 21, 2022

The world responded to the crisis at unprecedented speed, as leaders and experts focused on different ways to operate and succeed within the constraints of a new dynamic. One standout success we have all benefitted from is vaccine development, with […]

November 16, 2022

Babies born via cesarean section may not mount as strong an immune response after some childhood vaccines compared to babies delivered vaginally, researchers suggest. Antibody levels can be checked in blood or saliva, and babies born vaginally had higher levels […]

November 14, 2022

Shipments of the Beta-targeting booster are ready to be distributed to European countries as per advance purchase agreements, the companies said in a statement, in time for autumn/winter COVID-19 vaccination campaigns. “Today’s approval validates our research in developing a novel […]

November 11, 2022

The FDA’s choice marks the latest setback for the NurOwn program. When that key, late-stage clinical trial failed in late 2020, Brainstorm’s CEO Chaim Lebovits said the company was confident there would be a path forward for its medicine. Brainstorm […]

November 11, 2022

The European Commission has backed the use of the companies’ adjuvanted VidPrevtyn Beta vaccine – which targets the Beta variant of SARS-CoV-2 – as a booster vaccine candidate on the back of two “immunobridging” trials comparing it with currently-approved jabs. […]

November 10, 2022

Cancer cells acquire genetic changes that allow them to grow and proliferate unchecked. Researchers at the Dana-Faber Cancer Institute and colleagues have now found another difference between cancer cells and normal cells. The team analyzed public datasets comprising thousands of […]

November 9, 2022

Specifically, the treatment is indicated for patients with no epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK) or ROS1 aberrations, and those eligible for treatment must either have metastatic or locally advanced tumours that are not candidates for surgical […]

November 2, 2022

Priority Reviews are granted by the FDA in response to applications for vaccines that, if approved, have the potential to offer significant improvements in the safety or effectiveness of the treatment or prevention of critical conditions when compared to standard […]

November 1, 2022

The phase 3 MATISSE study of RSVpreF given to pregnant women in order to protect their babies after birth found that the vaccine had efficacy of 81.8% in preventing lower respiratory tract infections caused by RSV in the first 90 […]

October 27, 2022

A new study from scientists at La Jolla Institute for Immunology (LJI) has given researchers a guide to neutralizing the deadly Lassa virus (LSV) using a trio of rare antibodies isolated from survivors of Lassa virus infection. The LJI scientists […]

October 24, 2022

For over two years now, the US government has been running its public vaccination campaign – the largest in American history – and has purchased all of the Covid vaccines administered in the States, including over 500 million doses from […]

October 20, 2022

Americans will now have another choice if they want a COVID booster shot. On Wednesday, the U.S. Food and Drug Administration approved Novavax Inc.’s protein-based vaccine as a first booster dose. Until now, it had only been approved as a […]

October 19, 2022

The research provides some of the first evidence of a relationship between genetic factors and the way that people’s immune systems respond to COVID-19 vaccines. In the study, which was published in Nature Medicine, the researchers found that those carrying […]

October 18, 2022

The biotech and Gavi will cancel their existing supply deal for vaccines based on the original COVID-19 strain, which has led to the supply of nearly 70 million doses to the 92 Gavi COVAX Advance Market Commitment (AMC) low- and […]

October 17, 2022

Demand for nanoparticles in the biopharmaceutical industry is on the rise. Production of these tiny particles, which can protect and deliver medicines and vaccines where they need to go in the body, has been increasing since 1989. Over the last […]

October 17, 2022

Over half of the world’s population—nearly four billion people—are at risk of contracting dengue annually. The incidence of dengue has grown dramatically around the world in recent decades, causing an estimated 390 million infections and 500,000 hospitalizations annually. The rise […]

October 13, 2022

The bivalent vaccine contains mRNA encoding the original SARS-CoV-2 spike protein – present in the original Pfizer/BioNTech COVID-19 vaccine – together with mRNA encoding the spike protein of the Omicron BA.4/BA.5 subvariants. The booster has already been granted EUA by […]

October 11, 2022

The 30-subject study – funded by AZ and published in the Lancet journal eBioMedicine – tested two strengths of the current formulation of the vaccine administered as a nasal spray, with half the group receiving a second intranasal dose 28 […]

October 7, 2022

Ziphius Vaccines – a company developing vaccines and therapeutics based on self-amplifying RNA (saRNA), and UZ Ghent – have announced that they have entered a public-private collaboration. The link-up involves the scale up and manufacturing of prophylactic self-amplifying RNA vaccines […]